PHENTOLAMINE MESYLATE

Post-LOE

phentolamine mesylate

ANDAINJECTIONINJECTABLE
Approved
Jul 2017
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

CLINICAL PHARMACOLOGY Phentolamine Mesylate for Injection, USP produces an alpha-adrenergic block of relatively short duration. It also has direct, but less marked, positive inotropic and chronotropic effects on cardiac muscle and vasodilator effects on vascular smooth muscle. Phentolamine Mesylate…